Acelyrin, Inc.
SLRN
$2.12
-$0.05-2.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 65.41M | 116.54M | 124.07M | 120.09M | 104.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 293.46M | 630.05M | 680.54M | 630.21M | 589.31M |
| Operating Income | -293.46M | -630.05M | -680.54M | -630.21M | -589.31M |
| Income Before Tax | -248.23M | -264.41M | -299.80M | -240.16M | -381.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -248.23 | -264.41 | -299.80 | -240.16 | -381.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -248.23M | -264.41M | -299.80M | -240.16M | -381.64M |
| EBIT | -293.46M | -630.05M | -680.54M | -630.21M | -589.31M |
| EBITDA | -293.04M | -629.73M | -680.28M | -630.05M | -547.33M |
| EPS Basic | -2.50 | -2.68 | -3.06 | -2.60 | -10.85 |
| Normalized Basic EPS | -1.48 | -3.82 | -4.13 | -3.84 | -4.57 |
| EPS Diluted | -2.50 | -2.68 | -3.06 | -2.60 | -10.85 |
| Normalized Diluted EPS | -1.48 | -3.82 | -4.13 | -3.84 | -4.57 |
| Average Basic Shares Outstanding | 397.19M | 394.50M | 391.53M | 357.58M | 280.16M |
| Average Diluted Shares Outstanding | 397.19M | 394.50M | 391.53M | 357.58M | 280.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |